Kinfo
enVVeno Medical Corporation logo

enVVeno Medical Corporation

NVNONASDAQHealthcare·US · USD
$7.78
-0.37 (-4.54%)
Prices as of October 13, 2026 · live

Price

Key statistics

Valuation
Market cap5.66M USD
Enterprise value-15.25M USD
Trailing P/E-0.24
Forward P/E-1.41
PEG ratio0.00
Price / sales0.00
Price / book0.28
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-36.68%
Return on equity-58.53%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-17.26M USD
Net income-15.72M USD
Diluted EPS-$24.99
Rev. growth (YoY)0.00%
Balance sheet
Total cash21.49M USD
Total debt505.00K USD
Debt / equity2.44
Current ratio11.70
Book value / share$30.71
Cash flow (TTM)
Operating cash flow-14.62M USD
Levered free cash flow-9.59M USD
Shares & price
Shares outstanding655.52K
Float590.41K
Held by institutions15.96%
Beta1.29
50-day MA$10.02
200-day MA$10.66
52-week high$28.70
52-week low$7.01
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-30-4.69-5.37−14.50%2026-07-090.04-0.02−150.00%2026-05-15-0.53-0.61−15.09%2026-05-06-8.40-5.89+29.88%
About enVVeno Medical Corporation

enVVeno Medical Corporation is a medical device company focused on developing bioprosthetic, tissue-based solutions for venous disease. The company’s current portfolio centers on the VenoValve, a surgical replacement venous valve designed for patients with deep venous chronic venous insufficiency, and enVVe, a non-surgical, transcatheter-based venous valve system under development. These products are intended to address valve failure in the deep venous system and support more effective blood flow in patients with chronic venous disorders. enVVeno Medical Corporation serves the broader vascular medicine market, where it aims to improve treatment options for conditions that can cause pain, swelling, and long-term circulatory problems. Based in Irvine, California and incorporated in 1999, the company remains a late clinical-stage player in specialized medical technology, with a business model centered on advancing implantable and minimally invasive venous care solutions.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Robert A. Berman
Employees
37
Headquarters
Irvine, CA, United States

Frequently asked questions about enVVeno Medical Corporation